Ruth Exner
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Bone health and treatments
- HER2/EGFR in Cancer Research
Papers in
- Oncology 16
- HER2/EGFR in Cancer Research 7
- Cancer Diagnosis and Treatment 5
- Bone health and treatments 5
-
- Breast Cancer Treatment Studies 11
- Co-authors
- Florian Fitzal (28 shared papers)Barbara Wessner (2 shared papers)N. Manhart (2 shared papers)Erich Roth (4 shared papers)Andreas Spittler (3 shared papers)Michael Gnant (24 shared papers)Rudolf Oehler (5 shared papers)Eva-Maria Strasser (1 shared paper)
In The Last Decade
Ruth Exner
44 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 204
- Oncology 322
- Nutrition and Dietetics 105
- Biochemistry 48
- Drug Discovery 1
Countries citing papers authored by Ruth Exner
This map shows the geographic impact of Ruth Exner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Exner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Exner more than expected).
Fields of papers citing papers by Ruth Exner
This network shows the impact of papers produced by Ruth Exner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Exner. The network helps show where Ruth Exner may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth Exner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 180 | |
| 2 | 2019 | 153 | |
| 3 | Therapeutic potential of glutathione. | 2000 | 85 |
| 4 | 2022 | 77 | |
| 5 | 2003 | 46 | |
| 6 | 2013 | 45 | |
| 7 | 2003 | 41 | |
| 8 | 2002 | 40 | |
| 9 | 2017 | 34 | |
| 10 | 2019 | 33 | |
| 11 | 2016 | 31 | |
| 12 | 2020 | 24 | |
| 13 | 2021 | 23 | |
| 14 | 2015 | 23 | |
| 15 | 2014 | 23 | |
| 16 | 2017 | 22 | |
| 17 | 2016 | 18 | |
| 18 | 2023 | 17 | |
| 19 | 2011 | 16 | |
| 20 | 2018 | 16 |
About Ruth Exner
Ruth Exner is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (7 papers), Brain Metastases and Treatment (6 papers), Breast Implant and Reconstruction (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Cancer Diagnosis and Treatment (5 papers), Bone health and treatments (5 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Cancer Research (204 citations), Oncology (322 citations), Nutrition and Dietetics (105 citations), Biochemistry (48 citations) and Drug Discovery (1 citation). Ruth Exner has collaborated with scholars based in Austria, Lithuania and Germany. Frequent co-authors include Florian Fitzal, Barbara Wessner, N. Manhart, Erich Roth, Andreas Spittler, Michael Gnant, Rudolf Oehler, Eva-Maria Strasser, R. Jakesz and Kerstin Wimmer. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Therapeutic Advances in Medical Oncology, Breast Cancer Research and Treatment and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.